建发致新：与科赛尔医疗合作血管介入产品分销业务，预计年度规模约1亿元

Core Viewpoint - The company has entered into a distribution partnership with Koseir Medical, focusing on vascular intervention products, with an expected annual distribution scale of approximately 100 million yuan [1] Group 1 - The collaboration with Koseir Medical primarily involves the distribution of vascular intervention products [1] - The anticipated annual distribution scale from this partnership is around 100 million yuan [1] - The actual implementation of the distribution in 2026 may be influenced by factors such as channel expansion, introducing a degree of uncertainty [1]